Tech Company Financing Transactions
Opticyte Funding Round
Opticyte closed a $4.6 million Seed financing round on 1/13/2021. Investors included Starfish Ventures, Swan Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/13/2021
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Seed
Investors
Starfish Ventures (Lead Investor)
Swan Ventures (Lead Investor)
Proceeds Purpose
The recent funding will pay for the hiring of three part-time employees to help with data collection.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Mason Rd. 300
Seattle, WA 98195
USA
Seattle, WA 98195
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We're solving a big problem in medicine at Opticyte and because of our work, I have no doubt lives will be saved. I've dedicated my career to researching, understanding, and building a new technology needed to reveal a critical, missing -- and life-saving -- insight for clinicians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Robert Barry
Chief Executive Officer
Lori Arakaki
Chief Medical Officer
Ken Schenkman
Browse more venture capital transactions:
Prev: 1/13/2021: Earli venture capital transaction
Next: 1/13/2021: Modern Treasury venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs